The FLC Test Passed - But It Wasn't the Only Thing Being Tested
Last quarter's post flagged that Coupang's April 2023 change to its Fulfillment and Logistics by Coupang (FLC) merchant program would shrink reported revenue starting Q2 2023 "with no significant corresponding impact on gross profit" - a specific, falsifiable prediction sitting in the company's own words. It landed exactly as described: total net revenue grew 16% (21% constant currency»), still comfortably double-digit even with the reclassification's drag, while gross profit grew a full 32% to $1,523.8 million and gross margin expanded to 26.1% from 22.9% a year earlier. Revenue decelerating relative to gross profit by design, on a disclosed accounting change rather than a demand slowdown, is precisely the scenario the company told investors to expect - and the market got the chance to prove whether it actually read that footnote.
The bigger story this quarter isn't the FLC mechanics working as advertised, though - it's what's happening underneath the consolidated numbers. Adjusted EBITDA» hit a record $300.2 million (margin 5.1%), the fifth straight quarter of sequential improvement without a single step back: $(90.9)M → $66.2M → $194.9M → $211.0M (implied) → $240.9M → $300.2M. That's a genuinely rare run for a company barely two years removed from its IPO. But both segments didn't get there together. Product Commerce's Segment Adjusted EBITDA margin kept expanding - to 7.2% of segment revenue, up from 5.1% just one quarter earlier - while Developing Offerings' loss more than doubled quarter-over-quarter, from $(47.5) million to $(107.4) million, on revenue that grew only 10% sequentially. One segment is compounding margin gains; the other just posted its worst quarterly loss margin (-68.7% of its own revenue) since the two-segment structure began. A record consolidated number is doing a good job of masking a segment story that's moving in opposite directions (see Segment Performance below).
The Prescription
Coupang should now put a number on Developing Offerings, not just a direction. The segment's loss has widened for two straight quarters in dollar terms even as management describes "continued investments in our Eats and Taiwan offerings, and higher content costs for our Coupang Play offering" - three different bets bundled into one loss line, with no disclosure of which is closest to break-even, which is a multi-year build, and which might be cut. Investors are currently asked to trust that Product Commerce's expanding margin can keep funding an accelerating Developing Offerings loss indefinitely; that trust would be much easier to extend with segment-level detail on Eats, Play, and Taiwan individually, the way Product Commerce vs. Developing Offerings itself only became visible once Coupang adopted two-segment reporting in Q1 2022.
What it should stop doing: letting Developing Offerings' widening loss run alongside a doubling of collateral-backed borrowing at the same time (long-term debt outstanding rose to $904 million from $667 million at year-end, plus a new $61 million short-term facility in April). Q4 2022's post and Q1 2023's post both flagged this same pattern - new secured borrowing arriving even as operating cash generation strengthens - and it's continued for a third straight review. If Product Commerce's cash generation is genuinely strong enough to self-fund Developing Offerings' losses (this quarter's $819.8 million of quarterly operating cash flow suggests it is), taking on more pledged-collateral debt on top of that undercuts the "we don't need it" argument every time it happens again.
Key Financial Metrics
Q2 2023 vs. Q2 2022, consolidated - reported in USD
Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this 10-Q's consolidated financial statements and MD&A tables, covering the fiscal quarter ended June 30, 2023.
| Metric | Q2 2023 | Q2 2022 | YoY |
|---|---|---|---|
| Total net revenues | $5,837.9M | $5,037.8M | ✅ +16% (+21% constant currency) |
| Gross profit | $1,523.8M | $1,153.8M | ✅ +32%, margin 26.1% vs 22.9% |
| Operating income (loss) | $147.6M | $(67.1)M | ✅ fourth straight profitable quarter |
| Adjusted EBITDA» | $300.2M | $66.2M | ✅ margin 5.1% vs 1.3% - a new record, fifth straight sequential gain |
| Net income (loss) | $145.2M | $(75.5)M | ✅ margin 2.5% vs -1.5%, fourth straight profitable quarter |
| Net cash provided by (used in) operating activities | $819.8M | $(18.3)M | ✅ swung positive, up from Q1's $501.3M |
| Free cash flow» | $449.9M | $(195.5)M | ✅ third straight positive quarter |
| Cash & cash equivalents (period end) | $4,473.2M | n/a | ✅ +18.0% vs Mar 2023's $3,792.2M |
This is the fourth consecutive quarter of positive net income and Adjusted EBITDA - Q1 2023 was the third - and the fifth straight quarter Adjusted EBITDA has grown sequentially without a single decline, a run this site hasn't recorded before for either metric (see above).
| Balance sheet metric | Jun 2023 | Mar 2023 | Change |
|---|---|---|---|
| Total assets | $10,687.0M | $9,710.3M | ✅ +10.1% |
| Total liabilities | $7,911.5M | $7,150.3M | ⚠️ +10.6% |
| Total stockholders' equity | $2,775.5M | $2,560.0M | ✅ +8.4% |
Liabilities grew slightly faster than equity this quarter for the first time since Q1 2023's post noted the opposite pattern - accounts payable rose $392 million and long-term debt rose $196 million quarter-over-quarter, together outpacing the $145.2 million reduction to accumulated deficit (which fell exactly in step with this quarter's net income, to $(5,506.5) million from $(5,651.7) million at Q1's end).
Segment Performance: Product Commerce vs. Developing Offerings
Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, and fintech).
| Metric | Product Commerce Q2 2023 | Product Commerce Q1 2023 | Developing Offerings Q2 2023 | Developing Offerings Q1 2023 |
|---|---|---|---|---|
| Net revenues | $5,681.6M | $5,658.3M | $156.3M | $142.2M |
| Revenue growth (sequential) | ✅ +0.4% | — | ✅ +9.9% | — |
| Revenue growth (YoY) | ✅ +16.5% | — | ⚠️ -2.5% | — |
| Segment Adjusted EBITDA | ✅ $407.6M (margin 7.2%) | $288.4M (margin 5.1%) | ⚠️ $(107.4)M (margin -68.7%) | $(47.5)M (margin -33.4%) |
Product Commerce kept doing exactly what it's done for four straight quarters now: Segment Adjusted EBITDA rose again in both dollar and margin terms, to $407.6 million and 7.2% of segment revenue, up from $288.4 million and 5.1% just one quarter ago. This isn't a plateau - it's still accelerating, and it's now generating more than the entire consolidated company's Adjusted EBITDA on its own, meaning Developing Offerings is a net drag Product Commerce is fully absorbing rather than a rounding error.
Developing Offerings' loss more than doubled quarter-over-quarter in dollar terms (from $(47.5) million to $(107.4) million) even though revenue grew 9.9% sequentially - the opposite combination from last quarter, when revenue fell 21% YoY while the loss narrowed. Management attributes the wider loss to "continued investments in our Eats and Taiwan offerings, and higher content costs for our Coupang Play offering," offset partially by lower Eats delivery costs - three distinct bets bundled into one number, with no segment-within-a-segment breakout to show which is closest to paying for itself (see The Prescription above).
Key Operational Metrics
| Metric | Q2 2023 (Jun 2023) | Q2 2022 (Jun 2022) | YoY |
|---|---|---|---|
| Active Customers | 19.713M | 17.885M | ✅ +10.2%, new record |
| Total net revenue per Active Customer | $296 | $282 | ✅ +5.0% |
| Quarter | Active Customers | Revenue per Active Customer |
|---|---|---|
| Q3 2022 | 17.992M | $284 |
| Q4 2022 | 18.115M | $294 |
| Q1 2023 | 19.010M | $305 |
| Q2 2023 | 19.713M | $296 |
Active Customers kept climbing to a fifth consecutive record - up nearly 700,000 sequentially - but revenue per Active Customer dipped from Q1's $305 to $296, the first sequential decline in this metric since early 2022. This is consistent with the FLC reclassification (see above) mechanically trimming reported revenue per customer even as the underlying customer base and spending both kept growing - a reader comparing this figure against Q1's without that context would wrongly read it as engagement cooling.
"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter.
Beyond the Usual
The IPO securities suit was amended mid-quarter to add outright fraud allegations
The Choi v. Coupang, Inc. et al class action - first surfaced in the FY2022 filing and still without a lead plaintiff as of Q1 2023 - was amended on May 22, 2023, adding claims of securities fraud under Sections 10 and 20 of the Securities Exchange Act of 1934, on top of the original Securities Act Sections 11, 12, and 15 claims over the IPO registration statement. This is a real escalation, not a status update: the original claims alleged misleading disclosure in a specific document; the amended claims allege fraud, a materially harder-to-prove but also more serious charge. Coupang still states it believes the action is without merit and that no reasonable estimate of loss can be made. A case that took nine months to add fraud allegations, still with no lead plaintiff named, is no longer a routine "remains pending" line item.
A five-year-old antitrust investigation into Coupang's own private-label business resurfaced in this filing, unresolved
This 10-Q disclosed that the Korean Fair Trade Commission's investigation into potential preferential treatment of Coupang's private-label subsidiary, Coupang Private Label Business (CPLB), remains open - the same broader CPLB self-preferencing probe first flagged in this site's Q2 2021 post, which opened June 28, 2021 and has now run more than two years without resolution. (A separate, narrower 2019 LGHH-complaint case was concluded with a roughly $3 million fine, as reported at the time.) Coupang states it cannot reasonably estimate any penalty or loss from the investigation. An open antitrust matter into whether a marketplace operator favors its own house-brand products - the same structural concern regulators have raised about Amazon - deserves tracking every time it resurfaces in a filing, not just the quarter it first appears.
Product Commerce's segment margin is now generating more profit than the entire consolidated company
Product Commerce's Segment Adjusted EBITDA of $407.6 million this quarter exceeds consolidated Adjusted EBITDA of $300.2 million by more than $107 million - exactly the size of Developing Offerings' loss. This isn't a new pattern in direction (Product Commerce has carried the whole company since Q3 2022), but the gap between the two segments' contributions is now the widest this site has recorded, which is the actual story behind an otherwise clean consolidated beat (see above).
Supplier-financing-program payables grew faster than accounts payable overall
Confirmed invoices owed to financial institutions under Coupang's supplier finance program rose to $403 million as of June 30, 2023, from $337 million at year-end - a 20% increase, versus accounts payable overall growing about 12.5% over the same period (Dec 2022 to Jun 2023). These arrangements let vendors get paid early (at a discount) by a bank rather than by Coupang directly, with Coupang settling the bank on its normal invoice terms - functionally a financing tool riding inside the payables line rather than a separate debt disclosure, worth watching as it grows faster than the payables base it sits inside.
The 2021 revolving credit facility quietly moved off LIBOR mid-quarter
Effective July 1, 2023 (just after this quarter's close), Coupang's 2021 revolving credit facility replaced LIBOR with the Secured Overnight Financing Rate (SOFR) as its benchmark, per an amendment reached during the quarter. No borrowings have ever been drawn under this facility, so the change has zero cash impact today - it's a housekeeping footnote tied to the industry-wide LIBOR phase-out rather than anything specific to Coupang's own credit standing, but it does confirm the facility remains fully undrawn and available as a $1.0 billion liquidity backstop.
Equity-based compensation grew faster than headcount-driving revenue this quarter
Total equity-based compensation expense was $86.4 million this quarter, up 18.5% year-over-year, with the operating, general and administrative portion ($83.0 million) growing faster (+20.3%) than total net revenues (+16%). RSUs outstanding grew net to 46.755 million units by quarter-end (from 35.178 million at year-start) despite 6.065 million vesting and 2.040 million being forfeited, as new grants of 19.682 million more than replaced both. Not alarming at this company's size, but a share-based dilution trend worth tracking - diluted weighted-average shares for the quarter reached 1,800.1 million, versus 1,779.5 million basic, meaning roughly 20.6 million shares of dilutive effect from outstanding awards this quarter alone.
Target Valuation Range
EV $27.4 billion, ~1.17x EV/Revenue. Bottom line: Coupang is trading at roughly the same 1.1-1.2x revenue multiple it's held for three straight quarters, despite Adjusted EBITDA setting a new record every one of those quarters - the market isn't yet paying up for the accelerating-profitability trend, it's just no longer discounting it either.
Coupang closed Q2 2023 (June 30, 2023) at $17.40, up 8.75% from $16.00 at the end of Q1 2023, and up 36.5% from $12.75 a year earlier. With 1,606,466,000 Class A shares and 174,803,000 Class B shares outstanding (1,781,269,000 total) at quarter-end, that implies a market capitalization of approximately $31.0 billion, up from $28.4 billion three months earlier.
Using cash, cash equivalents, and restricted cash (current and long-term) of $4.744 billion against total debt (short-term borrowings, current portion of long-term debt, and long-term debt) of approximately $1.137 billion, net cash comes to roughly $3.607 billion, putting enterprise value at approximately $27.4 billion.
| Market cap → enterprise value | Q2 2023 |
|---|---|
| Share price (period-end) | $17.40 |
| Shares outstanding (Class A + B) | 1,781,269,000 |
| Market capitalization | $31.0 billion |
| Net cash (cash & equivalents less total debt) | $3.607 billion |
| Enterprise value | $27.4 billion |
| EV/Revenue sanity check | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Enterprise value | $25.5 billion | $27.4 billion | up |
| EV/Revenue | 1.10x | 1.17x | up |
- EV/Revenue» using Q2 2023 revenue annualized ($5.838 billion × 4 = $23.35 billion): ~1.17x, up slightly from Q1 2023's ~1.10x.
- Using trailing-twelve-month revenue (FY2022's $20.583 billion, less H1 2022's $10.155 billion, plus H1 2023's $11.638 billion = $22.067 billion): ~1.24x, at the top of the 1.0-1.2x range this site has tracked since Q4 2022.
DCF and reverse DCF (illustrative only): ten quarters of public-company data now cover Q3 2021 through Q2 2023, including four consecutive quarters of GAAP profitability. Checking this quarter against Q1 2023's base case:
| Scenario | Assumption / outcome |
|---|---|
| Current (period-end close) | Actual EV/Revenue this quarter, for reference: 1.17x |
| Q1 2023 base case | The Q1 2023 base case called for Product Commerce to hold its profitable run-rate, Developing Offerings' loss to keep narrowing even as its revenue stayed under pressure, free cash flow to stay positive but off Q1's magnitude, and the multiple to hold roughly flat in the 1.0-1.2x range. Three of four landed close: Product Commerce didn't just hold, its margin expanded further; free cash flow stayed positive, just below Q1's level as predicted; and the multiple held in the predicted band, landing at the top of it (~1.17-1.24x). Developing Offerings' loss was the miss - instead of narrowing, it more than doubled in dollar terms even as its revenue grew (see Segment Performance above), the opposite mix from what the base case assumed. |
| Bear case for next quarter | Bear case for next quarter: Developing Offerings' widening loss continues without a segment-level explanation, the Choi v. Coupang fraud amendment (see Beyond the Usual above) draws a lead plaintiff and a concrete damages theory, and the market starts pricing in the possibility that Product Commerce's margin gains can't outrun Developing Offerings' burn indefinitely. |
| Base case for next quarter | Base case for next quarter: Product Commerce's margin keeps expanding at a slower pace than this quarter's jump, Developing Offerings' loss stabilizes without necessarily narrowing, free cash flow stays positive, and the multiple holds in the 1.1-1.3x range. |
| Bull case for next quarter | Bull case for next quarter: Developing Offerings' loss narrows again as the Eats/Taiwan/Play investments season, Active Customers and revenue per Active Customer both resume climbing together (rather than the mixed picture this quarter produced), and the multiple re-rates toward 1.4-1.6x on evidence that five-plus quarters of accelerating consolidated profitability is durable rather than Product Commerce alone propping up a still-unproven second segment. |
Coupang, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, via the company's SEC filings.